Oncolys BioPharma, Inc. – Trademark Portfolio
Entity Type: 03
Oncolys BioPharma, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TELOMESCAN and TELOMELYSIN. The owner is based in Tokyo.
2-3-9 Roppongi, Minato-ku
Tokyo 106-0032 , JP
Showing of trademarks Trademarks
Trademark Classifications
Oncolys BioPharma, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Oncolys BioPharma, Inc. have?
Oncolys BioPharma, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does Oncolys BioPharma, Inc. file in?
Oncolys BioPharma, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Oncolys BioPharma, Inc.'s most well-known trademarks?
Oncolys BioPharma, Inc.'s registered trademark portfolio includes well-known marks such as TELOMESCAN and TELOMELYSIN. These are among 2 currently registered trademarks in the portfolio.
What is Oncolys BioPharma, Inc.'s trademark registration success rate?
Oncolys BioPharma, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.